|
|
Post by cjm18 on Sept 24, 2016 13:02:52 GMT -5
Anyone else notice mannkind avoided bad talking sny before the court documents were released on the shareholders civil suit? Not the case since.
Two occasions now Mnkd was said not so nice things about them.
1) matt answered a question during his last presentation. Said he couldn't go over all they did wrong in just a few minutes. Then he mentioned a few things they did wrong. 2) article about lack of inhaler in their sample.
I don't think this is a coincidence.
|
|
|
|
Post by prosper on Sept 24, 2016 14:35:23 GMT -5
Does anyone know the status of Arbitration or if we have even applied for it? I am assuming Matt or surrogates are in negotiations for some form of "severance", but since we contractually can't sue we probably have to negotiate first to show good faith effort. It is painful to wait, but outcome of Arbitration would certainly be better after we have shown success where SNY didn"t
Stuck between a rock and a hard place since we could sure use the money.
|
|
|
|
Post by dictatorsaurus on Sept 24, 2016 14:44:20 GMT -5
Reading between the lines. Doesn't mean much, especially coming from Matt.
Focus should be on promoting and selling the product, not bashing Sanofi.
|
|
|
|
Post by cjm18 on Sept 24, 2016 15:02:37 GMT -5
Could just be that mannkind didn't want to complain about them while mannkind was still working with them before getting them completely out the door. There was a transition that began in January. And I recall a day in April of importance to that transition.
|
|
|
|
Post by cjc04 on Sept 24, 2016 15:08:30 GMT -5
This is a conversation I'm interested in, not the bashing of sny (as much as I'd enjoy that too, just not productive) but where are we in terms of a final separation? Was it supposed to be final by now? Is there a working timeline? I was hoping to get some clarity on this at the last cc but we only got one, bad, question answered.
|
|
|
|
Post by agedhippie on Sept 24, 2016 15:08:44 GMT -5
Does anyone know the status of Arbitration or if we have even applied for it? I am assuming Matt or surrogates are in negotiations for some form of "severance", but since we contractually can't sue we probably have to negotiate first to show good faith effort. It is painful to wait, but outcome of Arbitration would certainly be better after we have shown success where SNY didn"t Stuck between a rock and a hard place since we could sure use the money. The contract means that they couldn't tell us even if they wanted to. The fact the arbitration is underway, the evidence, and any judgement is all confidential. |
|
|
|
Post by cjc04 on Sept 24, 2016 15:20:22 GMT -5
Does anyone know the status of Arbitration or if we have even applied for it? I am assuming Matt or surrogates are in negotiations for some form of "severance", but since we contractually can't sue we probably have to negotiate first to show good faith effort. It is painful to wait, but outcome of Arbitration would certainly be better after we have shown success where SNY didn"t Stuck between a rock and a hard place since we could sure use the money. The contract means that they couldn't tell us even if they wanted to. The fact the arbitration is underway, the evidence, and any judgement is all confidential. [ Understood, but are we still on some planned schedule of separation? Or are we at a point yet where the silence can only mean they're in arbitration? |
|
|
|
Post by bthomas55ep on Sept 24, 2016 15:21:02 GMT -5
Reading between the lines. Doesn't mean much, especially coming from Matt. Focus should be on promoting and selling the product, not bashing Sanofi. You are right, the focus needs to be on promoting, educating, and selling the product. However, there is no doubt in my mind that a successful arbitration is one of the auxiliary fuel sources needed to complete this mission. I don't have any problems at all with a small legal team and an executive point person running hard on this to see if we can get the valve open on some much needed fuel (cash) so the journey can continue uninterrupted for now. The company in its current condition would be remiss if it wasn't making SNY arbitration a priority. I think successful product prescription growth trends go hand in hand. Side note, guess we will see a label change application by the end of this week? |
|
|
|
Post by centralcoastinvestor on Sept 24, 2016 15:31:03 GMT -5
I'm like totally OK with a thread dedicated to bashing Sanofi. Yes it doesn't do much good for selling Afrezza or the MannKind share price, but it makes me feel better.  |
|
|
|
Post by mannmade on Sept 24, 2016 15:34:01 GMT -5
Agree CCI and it's better than one dedicated to bashing Mnkd, Matt, et al...
|
|
|
|
Post by dictatorsaurus on Sept 24, 2016 15:40:11 GMT -5
What did Sanofi do to entitle Mannkind to anything?
I have no doubt they sandbagged, but this has to be proven over years and years in court and millions of dollars in legal fees.
|
|
|
|
Post by cjc04 on Sept 24, 2016 16:37:03 GMT -5
What did Sanofi do to entitle Mannkind to anything? I have no doubt they sandbagged, but this has to be proven over years and years in court and millions of dollars in legal fees. "Millions of dollars in legal fees" is fine with me, when HUNDREDS of millions are in question. |
|
|
|
Post by lakers on Sept 24, 2016 17:03:17 GMT -5
One of Matt's slide said successful negotiation of a settlement w/ Sny was vital, I paraphrased. You can dig up the slide.
I believe it's still on-going.
I agree with "outcome of Arbitration would certainly be better after we have shown success where SNY didn't."
A settlement should address $70M loan forgiveness to lift the lien on Danbury plant, Valencia HQ. It's dead money to Sny anyway. That's probably the first thing Sny will offer.
I would not rule out if EpiHale is part of the package since Sny dropped AviQ, EpiPen competition. Check Pfizer's settlement w/ Nektar, which includes a joint R&D deal.
|
|
|
|
Post by boytroy88 on Sept 24, 2016 17:58:39 GMT -5
One of Matt's slide said successful negotiation of a settlement w/ Sny was vital, I paraphrased. You can dig up the slide. I believe it's still on-going. I agree with "outcome of Arbitration would certainly be better after we have shown success where SNY didn't." A settlement should address $70M loan forgiveness to lift the lien on Danbury plant, Valencia HQ. It's dead money to Sny anyway. That's probably the first thing Sny will offer. I would not rule out if EpiHale is part of the package since Sny dropped AviQ, EpiPen competition. Check Pfizer's settlement w/ Nektar, which includes a joint R&D deal. But will MNKD be allowed to publicize the fact (if and when) they received any monetary relieve from SNY as settlement? |
|
|
|
Post by mannmade on Sept 24, 2016 19:00:58 GMT -5
Guess it depends as I am no expert in this area but must weigh constraints of any specific points of the settlement contained in an NDA (which is standard) vs what information is material to the need to know of shareholders in form of information/disclosures that triggers a need for an 8k.
|
|
